About peramivir
Intravenous neuraminidase inhibitor antiviral
Used for
- Treatment of acute uncomplicated influenza in adults and children aged 6 months or older.
Usual adult dose
600 mg by intravenous infusion once, over 15–30 minutes.
Usual dose in children
Children 6 months and older: 12 mg/kg once by intravenous infusion; maximum 600 mg.
Common side effects
- Diarrhea
- Nausea or vomiting
- Headache
- Rare serious skin or allergic reactions
Important warnings
- Start treatment as soon as possible; benefit is greatest when started early.
- Not a substitute for influenza vaccination.
- Adjust dose for reduced kidney function.
- Rare reports of confusion or unusual behavior, especially in children.
Pregnancy
Human pregnancy data are limited; use when clinically needed after weighing potential benefits and risks.
Breastfeeding
It is unknown whether peramivir enters breast milk; consider the mother's treatment needs and potential infant exposure.
Interactions
- No clinically significant drug interactions are well established.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.